27 Nov 2013 09:36
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
IDH.L Share News (IDH)
IDH Share
Price
IDH Share
News
IDH Share
Chat
IDH Share
Trades
IDH
Live RNS
IDH Share
Charts
IDH Broker
Ratings
IDH Directors
Deals
IDH Financial
Diary
IDH
Fundamentals
IDH Short
Positions
IDH
Media
IDH.L Information
- There is currently no data for IDH
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Immunodiagnostic revenues shrink as clients move on
Wed, 22nd Jun 2016 16:22
(ShareCast News) - Immunodiagnostic Systems reported a 15.6% decline in revenues for the year to 31 March on Wednesday, to £38.3m.The AIM-traded firm said that excluding the acquisition of Diametra and at constant exchange rates the decline was even larger at 18.4%.Its board reported automated revenues as being 48% of overall revenues at £18.3m, a decline of £3.7m.Immunodiagnostic said it was continuing to lose automated 25-OH Vitamin D business as the larger laboratories migrate test volumes previously run on its iSYS analyser to high-throughput analysers.Manual assay revenues were now contributing 33% of overall revenues, and were down 17.8% at £12.7m.It put this loss down to test volumes continuing to be lost to automated solutions offered both by itself and other businesses, coupled with weaknesses in the sales process.The company added a non-cash impacting exceptional impairment charge of £38.2m to write down intangible assets and goodwill to their recoverable amount.Immunodiagnostic's adjusted EBIT stood at £0.5m before exceptional items, down from £4.2m last year, with adjusted basic earnings per share of 4.7p, down from 11.1p.Statutory EBIT was a loss of £36.8, compared with earnings of £3.3m in 2015, and statutory basic losses per share were -109.7p, compared to earnings of 8.1p in the prior year.Net cash flow from operations totalled £8.2m, down from £8.8m, although free cash flow grew to £3.2m from £2.6m.The company had closing cash and equivalents of £26.6m, an increase of 12.2% from 2015's £23.7m."IDS is going through a profound and exciting transformation process," said CEO Patricio Lacalle."As we continue to lose commodity business to the big players we are building and expanding our speciality portfolio."Lacalle said the transformation was taking longer than expected, but is happening continuously with the company gaining momentum in the change process."Our teams understand the necessity for change across all functions and the need to adapt our cost structures."We strive towards actively engaging our internal talents as well as complementing our skills with talent from the outside," Lacalle explained.
More News
27 Nov 2013 09:14
Wednesday broker round-up UPDATE
Aviva: Nomura moves target price from 474p to 489p retaining a buy recommendation. Bellway: Numis upgrades to buy with a target price of 1690p. Breedon Aggregates: Jefferies starts with a target price of 42p and a buy recommendation. Britvic: UBS ups target price from 575p to 600p and keeps a neu
Read more27 Nov 2013 07:57
25 Nov 2013 10:13
25 Nov 2013 08:00
Monday broker round-up UPDATE
African Barrick Gold: Goldman Sachs ups target price from 110p to 140p, but still recommends selling. Alternative Asset Opps: Westhouse Securities initiates with a buy recommendation. Amino Technology: Northland Capital cuts target price from 110p to 100p and downgrades from buy to hold. Asian Pl
Read more10 Oct 2013 08:36
Thursday broker round-up UPDATE
Ashmore Group: Canaccord Genuity takes target price from 380p to 400p and retains a hold recommendation. Numis shifts target price from 380p to 390p reiterating its hold recommendation. Ashtead Group: Numis upgrades to add with a target price of 670p. Berkeley Group: Panmure Gordon moves target pr
Read more10 Oct 2013 08:32
Immunodiagnostic Systems returns to growth in first half
Faster revenue growth from its automatic diagnostic testing technology helped Immunodiagnostic Systems (IDS) return to growth in the first half, with first-half declines in its older manual devices also slower than expected. IDS said total revenues for the six months to September 30th would swell
Read more2 Jul 2013 15:41
Ashtead execs sell off awards after share-price surge
Equipment rental business Ashtead has seen a number of board-members sell off their share awards given to them as part of their performance share plan (PSP) in June 2010. Awards given to executives under the PSP vest on the third anniversary of grant subject to continued employment and the achievem
Read more17 Jun 2013 07:33
Immunodiagnostic Systems revenues shrink
Immunodiagnostic Systems posted reduced revenues, in the wake of tough trading conditions, as it puts in place a strategy to return the group to growth. The Newcastle-upon-Tyne based group, which makes manual and automated specialist diagnostic testing kits and instrumentation for the clinical and
Read more17 Jun 2013 07:21
Monday broker round-up UPDATE
Antofagasta: UBS reduces target price from 1140p to 1050p, while upgrading from neutral to buy. ARM Holdings: Analysts at Numis have cut their view on the shares to reduce from hold. Associated British Foods: Nomura cuts target price from 1800p to 1650p downgrading to reduce. Atkins: Jefferies u
Read more12 Jun 2013 07:55
Wednesday broker round-up UPDATE
Aberdeen Asset Management: Canaccord Genuity cuts target price from 460p to 440p, while leaving its buy recommendation unchanged. ASOS: Canaccord Genuity downgrades to hold with a target price of 3400p. BT Group: Credit Suisse increases target price from 300p to 350p and maintains an outperform ra
Read more10 Apr 2013 08:57
Wednesday broker round-up UPDATE
African Barrick Gold: Westhouse Securities upgrades from sell to neutral with a target price of 195p. Deutsche Bank reduces target price from 340p to 230p keeping its hold rating. African Minerals: Deutsche Bank reduces target price from 620p to 594p and leaves its buy recommendation unaltered. An
Read more10 Apr 2013 08:53
IDS update proves resilience and cash generation
Revenues from medical diagnostics group Immunodiagnostic Systems to the end of March will be marginally reduced on the previous year but in line with expectations. In a year-end trading update, the Newcastle-upon-Tyne based company said total revenues would hit £49.8m for the year to March 31st, d
Read more5 Apr 2013 16:55
Belvoir Lettings Chairman sells shares to satisfy institutional demand
Belvoir Lettings, the UK lettings specialist which listed on the AIM market in February last year, announced on Friday that its Executive Chairman and founder had sold a quarter of a million shares in the group in order to help satisfy 'significant institutional demand'. The news comes just a week
Read more